Learn More
Invitrogen™ Epratuzumab Chimeric Recombinant Rabbit Monoclonal Antibody (hL22 (Epratuzumab))

Description
Specificity: This antibody is specific for the 3rd Ig-like domain of human CD22 (epitope B), a cell surface glycoprotein present on mature B-cells and on many types of malignant B-cells.
Specifications
Specifications
| Antigen | Epratuzumab Chimeric |
| Applications | Flow Cytometry, Inhibition Assays, Immunoprecipitation |
| Classification | Recombinant Monoclonal |
| Clone | hL22 (Epratuzumab) |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% ProClin 300 |
| Gene Alias | 90Y-DOTA-hLL2; 90Y-epratuzumab tetraxetan; 90Y-hLL2; AMG-412; hLL2 |
| Host Species | Rabbit |
| Immunogen | This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.